Lurbinectedin Displays Superior Risk/Benefit Ratio Over Topotecan in SCLC
Lurbinectedin demonstrated greater activity and a superior safety profile vs topotecan in a subset of small cell lung cancer.
Source: onclive.com
Stay updated with breaking news from Alkylating Agent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lurbinectedin demonstrated greater activity and a superior safety profile vs topotecan in a subset of small cell lung cancer.
Eno-Abasi Inyang, PharmD, BCPS, BCOP provides an overview of the various conditioning regimens employed for allogeneic stem cell transplantation.
Alkylating agent, any highly reactive drug that binds to certain chemical groups (phosphate, amino, sulfhydryl, hydroxyl, and imidazole groups) commonly found in nucleic acids and other macromolecules, bringing about changes in the DNA and RNA of cells. Alkylating agents were the first anticancer